Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. COVID-19 in people with multiple sclerosis: A global data sharing initiative

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Predictors of treatment outcome in patients with paediatric onset multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Reproductive history of the Danish multiple sclerosis population: A register-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Aggressive multiple sclerosis (1): Towards a definition of the phenotype

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Aggressive multiple sclerosis (2): Treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The Extracellular Polysaccharide Matrix of Pseudomonas aeruginosa Biofilms Is a Determinant of Polymorphonuclear Leukocyte Responses

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Protein array-based companion diagnostics in precision medicine

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Biomarkers of inflammation and epithelial barrier function in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Treatment with interferon-beta (IFN-beta) increases B-cell activating factor of the TNF family (BAFF) expression in multiple sclerosis (MS), raising the concern that treatment of MS patients with IFN-beta may activate autoimmune B cells and stimulate the production of MS-associated autoantibodies.
Original languageEnglish
JournalMultiple Sclerosis
Volume17
Issue number5
Pages (from-to)567-77
Number of pages11
ISSN1352-4585
DOIs
Publication statusPublished - 1 May 2011

ID: 32672948